Payers

IMPROVE YOUR STANDARD OF CARE TO LOWER PER-MEMBER COSTS

Glooko is clinically proven to deliver superior outcomes at three months and beyond one year to help keep your members healthier*

*Remote Patient Monitoring in the Real World: Immediate and Long-Term Improvements in Glycemic Control. Sheng, T et al. American Association of Diabetes Educators (AADE) Emerging Science Poster, 2019

EXPAND
THE PATIENT—DOCTOR CONNECTION

  • Glooko enables patients to collaborate with a broader care team
  • Unlike other solutions, there is no disruption to the patient-doctor relationship
  • Glooko is a comprehensive solution for all diabetes patients, not just people with type 2 diabetes

Facilitate collaboration of
care management teams

  • Connecting population health teams, HCPs and members to coordinate care
  • For in-clinic visits, the Glooko Transmitter automatically detects the diabetes device and uploads data to the cloud
  • Using the web app, HCPs and broad care management teams can increase standards of care by enabling more frequent patient interaction and constant remote patient monitoring
Glooko System
glooko phone patients

Easy-access mobile app
for patients

  • Glooko mobile application empowers members to take control of their diabetes between appointments
  • Members can synchronize data from all of their devices, receive alerts and analyze their diabetes data in easy-to-understand visualizations
  • Members can receive reminders for care plan adherence, share data with care teams and take advantage of remote patient monitoring programs

Industry-leading sustainable outcomes

Improved outcomes within 3 months – increasing and sustainable after 1 year

Reduction
In HbA1c

  • 0.8% at 3 months
  • 1.2% for patients >=8.5% at 3 months
  • 0.82% at 6 months
  • 1.46% for patients >=8.5% at 6 months

Decreased Average
Blood Glucose

  • 18.0% at 3 months
  • 18.8% after 6 months
  • 15.7% after 12 months

Increased In-Range
Blood Glucose

  • 29.4% at 3 months
  • 29.7% after 6 months
  • 29.8% after 12 months

Decreased
Hyperglycemia

  • 12.3% at 3 months
  • 12.7% after 6 months
  • 12.0% after 12 months

Remote Patient Monitoring in the Real World: Immediate and Long-Term Improvements in Glycemic Control. Sheng, T et al. American Association of Diabetes Educators (AADE) Emerging Science Poster, 2019